Skip to main content
PLOS One logoLink to PLOS One
. 2025 Mar 11;20(3):e0318502. doi: 10.1371/journal.pone.0318502

Respiratory rate and its associations with disease and lifestyle factors in the general population – results from the KORA-FF4 study

Ina-Maria Rückert-Eheberg 1,*,#, Alexander Steger 2,3,#, Alexander Müller 2, Birgit Linkohr 1,3, Petra Barthel 2, Melanie Maier 2, Julia Allescher 2, Moritz F Sinner 3,4, Konstantinos D Rizas 3,4, Wolfgang Rathmann 5,6, Karl-Ludwig Laugwitz 2,3,4, Stefan Kääb 3,4, Annette Peters 1,3,7,, Georg Schmidt 2,4,
Editor: Xiangwei Li,8
PMCID: PMC11896064  PMID: 40067853

Abstract

Objective

The aim of the study was to derive median age- and sex-specific respiratory rates in a population-based sample of adults and to identify disease and lifestyle factors associated with elevated respiratory rates.

Methods

In the population-based KORA FF4 study conducted in Augsburg, Germany, 5-minute 12-lead resting electrocardiograms (ECGpro-system, AMEDTEC) were recorded in 2,224 participants from 39 to 88 years. Respiratory rate was derived from these electrocardiograms. Sex- and age-specific medians, IQRs, and percentiles were calculated. Associations of sociodemographic, disease, and lifestyle variables with elevated resting respiratory rate were assessed by univariable and multivariable logistic regression analyses.

Results

Respiratory rate decreased slightly from youngest to middle-aged women and men and increased in old age. Overall, median (IQR) was 15.80 (3.16) breaths per minute (brpm). Five percent of the participants had values lower than 12.06 brpm, and five percent had values above 20.06 brpm (95th percentile). Elevated respiratory rates of ≥  18.6 brpm were found in 13.8% (n =  308). In an adjusted logistic regression model, age, abdominal obesity, diabetes, COPD, smoking, and low education were significantly associated with elevated respiratory rate. Stratified analyses showed that education appeared to be more relevant in women, while the effect of diabetes was more pronounced in men.

Conclusions

High respiratory rate may be an indicator of impaired health in the general population, especially regarding pulmonary and metabolic characteristics, and unfavorable lifestyle and living conditions. Individuals with an increased respiratory rate should therefore be examined and followed up more closely to recognize diseases and adverse progressions at an early stage and to possibly prevent them.

Introduction

In the Book of Prognostics, written 400 B.C.E., Hippocrates emphasized the diagnostic importance of breathing: “Respiration, when frequent, indicates pain or inflammation in the parts above the diaphragm: a large respiration performed at a great interval announces delirium; but a cold respiration at nose or mouth is a very fatal symptom. Free respiration is to be looked upon as contributing much to the safety of the patient in all acute diseases, such as fevers, and those complaints which come to a crisis in forty days.” [1].

Today, it is generally recognized that, similar to heart rate, blood pressure, and body temperature, respiratory rate is a crucial vital sign to assess a person’s state of health as it varies acutely with exertion, stress, fever, and sepsis. According to the “Third International Consensus Definitions for Sepsis and Septic Shock”, the quick SOFA score including altered mentation, systolic blood pressure of 100 mm Hg or less, and respiratory rate of 22/min or greater, provides simple bedside criteria to identify adult patients with suspected infection who are likely to have poor outcomes [2].

Respiratory rate has been identified as an indicator of clinical deterioration and mortality in hospitalized patients [35] and older outpatients [6, 7] on the one hand. On the other hand, recent studies have shown that slow breathing or breathing techniques derived from Yoga, Zen or Qi Gong may be able to regulate blood pressure [8], increase cognitive function and reduce anxiety and stress [9, 10], alleviate pain [11], and improve symptoms of depressive disorder [12]. Nevertheless, respiratory rate has often been disregarded [13] or regretfully termed ‘neglected vital sign’ [14] in the past and it is still unclear how to react if the wearable or the monitor in the clinic indicates an increased respiratory rate, what the expected frequency spectrum is, and if respiratory rate indicates existing, previously undiagnosed comorbidities. These questions require evidence from large observational studies.

A description of sex- and age-specific normal values is needed to estimate the severity of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and pneumonia, to define fitness levels, and to describe tachypnoea [15]. To date, there is no firm evidence on the distribution of resting respiratory rate in the general adult population. A study in non-institutionalized elderly participants in Spain found that the 2.5–97.5-percentiles were 12.0–28.2 breaths per minute (brpm) in those aged>=65 years and 9.8–30.0 brpm in those aged>=80 years [16]. Evidence-based normal values have not been defined so far and guidelines are based on clinical consensus only.

Autonomic functionality and interactions of the autonomic nervous system with the cardiovascular and respiratory systems can be quantified by ECG-derived autonomic parameters, such as respiratory rate, heart rate and deceleration capacity, a heart rate variability parameter reflecting the vagally mediated regulation of the heart rate. Based on these parameters, the prognosis of patients with cardiovascular diseases can be estimated fairly well [1720]. In a study including patients who survived acute myocardial infarction, a Polyscore of autonomic parameters derived from ECG, blood pressure, and respiration strongly predicted cardiac and all-cause mortality and was able to identify patients with a very low mortality risk [21]. Moreover, there is some evidence on the prognostic utility of these parameters in the general population [22]. It is still crucial to analyze the individual components of such scores in more detail.

Little is known about the correlations of respiratory rate with sex and age, life-style related risk factors, and clinical variables. Baumert et al. conducted an observational study on the association of nocturnal mean respiratory rate and mortality among community-dwelling older men and women. They found that in men, respiratory rate increased with age, body mass index (BMI), and systolic blood pressure and was higher in those with diabetes, asthma or COPD, smokers, and those with lower alcohol consumption. All associations were statistically non-significant in women; however, women were underrepresented in this cohort [7]. Furthermore, it has been found that respiratory rates are shaped by genetic, physiological, and environmental factors. In particular, high-a[ltitude environments expose individuals to hypoxia, leading to adaptations that affect breathing patterns [23].

The objective of this study was to derive the resting respiratory rate from 5-minute 12-lead electrocardiograms in a population-based study in Southern Germany and examine associations between increased respiratory rate and socioeconomic, lifestyle, and clinical factors. In addition, we assessed its correlation with heart rate, since the respiratory and cardiovascular systems are closely linked via autonomous interactions and reflexes. The two parameters do not depict the same mechanisms but are often altered concordantly.

Methods

KORA study and participant selection

KORA (Cooperative Health Research in the Region of Augsburg) is a population-based health cohort in the city of Augsburg and two surrounding counties

Augsburg and Aichach-Friedberg, in Southern Germany [24]. Briefly, the participants were randomly selected in a sex- and age-stratified manner from population registries from all inhabitants with main place of residence in the study region and German nationality in four cross-sectional surveys from 1984–2001. In 1999–2001, 4,261 participants from 25 to 74 years were enrolled in the KORA S4 study.

The KORA FF4 study is the second follow-up of the KORA S4 study conducted from 03.06.2013 to 27.09.2014. Participants of KORA S4 were considered ineligible for FF4 if they died (n = 455, 10.7%), lived too far outside the study region or were completely lost to follow-up (n = 296, 6.9%), or had requested deletion of their address data (n = 191, 4.5%). Of the remaining 3,319 eligible persons, 157 could not be contacted, 504 were unable to attend the study centre, and 379 were not willing to participate in this follow-up, resulting in a response rate of 68.7% and a FF4 study population of 2,279 participants [25] (Fig 1).

Fig 1. Flow chart of the study population.

Fig 1

The study was carried out in accordance with the Declaration of Helsinki. This included written informed consent from all participants and approval of the surveys by the ethics committee of the Bavarian Chamber of Physicians, Munich (FF4 EC No. 06068).

Electrocardiogram recoding

A 5-minute 12-lead resting electrocardiogram (ECGpro-system, Fa. AMEDTEC) was recorded in all participants. The electrocardiograms were digitally stored and semi-automatically analyzed. After initial algorithm-based processing, the electrocardiograms were reviewed by experienced professionals. If necessary, artefacts were removed and QRS classifications were corrected manually to obtain an accurate sequence of heartbeat intervals.

Respiratory rate was indirectly calculated from the electrocardiogram tracings as previously described [26]. Respiratory activity influences oscillations of beat-to-beat intervals, amplitudes of QRS complexes, and QRS vector angles and magnitudes. Time series of these parameters were derived. For each time series, all local maxima were identified and the mean interval duration between consecutive local maxima was determined. Respiratory rate was then calculated from the median of these reciprocal interval durations [26]. According to previous studies, elevated respiratory rate was prespecified at more than or equal to 18.6 breaths per minute (brpm) [26, 27]. This was equivalent to the 86th percentile in the data used here.

Of the 2,279 participants in FF4, we excluded those with missing data on respiratory rate leaving n =  2,224 participants.

Covariates

At the KORA study center, an interview, physical examination, and a blood withdrawal were performed by trained staff. Self-reported information on the demographic variables sex, age, and living alone or with a partner, socioeconomic factors such as school education (low/secondary school, middle/secondary school leaving certificate, high/A-levels) reported at baseline and lifestyle factors including smoking (never smoker, ex-smoker, (occasional and regular) smoker), and physical activity (based on leisure activity during summer and winter (regularly > 2 hours/week, regularly about 1 hour/week, irregularly about 1 hour/week, almost none or none)) [28] were collected in a standardized computer-assisted personalized interview. Alcohol consumption was assessed using a validated recall method in which participants were asked how much beer, wine, and spirits they consumed on the previous weekday and weekend [29]. No alcohol consumption was defined as 0 g/day, moderate alcohol consumption as 0.1–39.9 g/day for men and 0.1–19.9 g/day for women and heavy alcohol consumption as ≥  40 g/day for men and ≥  20 g/day for women. The participants were asked whether they’ve had a myocardial infarction, a stroke, cancer, a diagnosis of chronic obstructive pulmonary disease (COPD) or of asthma. Depressive symptoms were assessed by the Brief Patient Health Questionnaire (PHQ-D short version). Current hypertension was defined as blood pressure of ≥  140/90 mmHg or known hypertension treated with medications. Waist circumference (WC) was measured to the nearest 0.1 cm at the midpoint between the lower margin of the least palpable rib and the top of the iliac crest with stretch-resistant tapes. Abdominal obesity was defined as a WC of > 88 cm in women and > 102 cm in men [30]. Diabetes status was assessed by an oral glucose tolerance test (OGTT) that was performed in all participants without known diabetes as described previously [31] (S1 Table).

Statistical analyses

In subgroups of sex and age, respiratory rate and heart rate were analyzed by computation of medians, interquartile ranges, and percentiles. QQ-plots, Shapiro-Wilk- and Kolmogorov-Smirnov tests were used to check for normal distributions and Kendall’s rank correlation tau as well as Spearman’s rho were applied to analyze the correlation of the two variables.

Participant characteristics were compared between subgroups with normal and elevated respiratory rates using univariable logistic regression models. Adjusted odds ratios with 95% - confidence intervals were obtained from multivariable logistic regression models. Biological and clinical plausibility and the avoidance of multicollinearity were main criteria for the selection of the covariables. Multicollinearity was checked by calculating the variance inflation factor (VIF) and variables with values >  5 were excluded from the model. Significance was assumed for a two-sided p < 0.05. All statistical analyses were performed using R4.2.1 and R-Studio (Boston, MA, USA).

Results

Study population

The study population included 2,224 participants (1,069 men and 1,155 women) of the KORA FF4 study with complete data on respiratory rate. The age ranges in both sexes were 39 to 88 years (mean age in men 61.1 ± 12.6 years and in women 60.1 ± 12.1 years).

Respiratory rates in the whole study population and by sex and age

In all 2,224 participants, respiratory rate at rest ranged from a minimum of 9.19 brpm to a maximum of 28.17 brpm. Median and IQR were 15.80 brpm and 3.16 brpm, respectively. In participants 39 to 48-years-old, median respiratory rate was 15.62 brpm, 15.26 brpm in those from 49 to 58 years-old, 15.80 brpm in those from 59 to 68 years-old, 16.15 brpm in those from 69 to 78 years-old, and 17.01 brpm in those from 79 to 88 years-old. Five percent of the participants had values lower than 12.06 brpm (5th percentile) and 5% of participants had values above 20.06 brpm (95th percentile). In 13.8% (n =  308) of the participants, resting respiratory rate was higher than or equal to 18.6 brpm. The percentages of participants with an elevated respiratory rate of ≥  18.6 brpm were 11.7% in those at ages 39 to 48 years, 9.6% in individuals at ages 49 to 58 years, 14.0% in those at ages 59 to 68 years, 16.2% in individuals at ages 69 to 78 years, and 24.9% in those between the ages of 79 to 88 years.

Age dependency was observed in both sexes. In men, mean respiratory rate was slightly higher in participants at ages 39 to 48 years (15.37 brpm) than in those from 49 to 58 years-old (15.16 brpm) and highest in the older age groups (e.g., 16.91 brpm in participants at ages 79 to 88 years). Consistently in women, median respiratory rate was 15.80 brpm in the youngest age group, 15.33 brpm in the second youngest age group, and 17.07 brpm in the oldest age group (Table 1).

Table 1. Respiratory rate (breaths per minute, brpm) by age and sex.

Age Sex N Min Max Median IQR Quantile 5 Quantile 25 Quantile 75 Quantile 95 Respiratory rate ≥  18.6 brpm
39–48 y. Men 221 10.31 28.17 15.37 3.51 11.35 13.46 16.97 19.25 12.2%
Women 251 9.19 24.53 15.80 2.77 12.09 14.28 17.05 19.55 11.2%
49–58 y. Men 254 9.47 21.94 15.16 3.16 11.57 13.69 16.85 19.88 10.2%
Women 288 9.50 21.12 15.33 2.79 11.79 14.12 16.91 19.72 9.0%
59–68 y. Men 254 10.67 22.26 15.68 3.03 12.28 14.14 17.17 20.29 13.0%
Women 302 10.22 24.56 15.92 3.05 12.26 14.53 17.58 19.81 14.9%
69–78 y. Men 234 9.92 22.25 16.26 3.17 12.76 14.62 17.79 20.41 17.9%
Women 223 10.54 22.33 16.06 2.87 12.82 14.79 17.66 19.92 14.3%
79–88 y. Men 106 10.45 22.59 16.91 3.03 12.88 15.46 18.49 20.76 24.5%
Women 91 11.99 22.93 17.07 3.44 13.88 15.14 18.58 21.16 25.3%

Respiratory rate was approximately normally distributed, and most outliers were found in the youngest age group (Figs 2 and 3).

Fig 2. Scatterplots of respiratory rate and age by sex.

Fig 2

Fig 3. Violin-boxplot of respiratory rate by age and sex.

Fig 3

Dashed red line indicates cut point of 18.6 brpm for elevated values; blue (median) and grey lines (from bottom to top: 5th, 25th, 75th, 95th-percentiles) derived by quantile regression.

Associations of elevated respiratory rate with disease and lifestyle factors

Various clinical and lifestyle factors differed between participants with normal versus elevated respiratory rates (S2 Table). Individuals with elevated respiratory rate were more often in the three oldest age groups. They had more comorbidities such as a history of stroke, obesity, arterial hypertension, and chronic obstructive pulmonary disease. Additionally, they were less physically active, had a lower school education, lived alone more often, and had more depressive symptoms.

Table 2 is a regression table and shows frequencies and percentages of normal vs. elevated respiratory rates in groups of individuals with certain disease and lifestyle characteristics, including univariable regression results. Univariable ORs for a high respiratory rate were significant in the two oldest age groups (vs. the youngest age group), the lowest (vs. the highest) school education, abdominal obesity, physical inactivity, smoking (vs. never-smoking), living without a partner, previous stroke, depressive symptoms, hypertension, COPD, (pre)-diabetes, and heart rate. A protective effect in the univariable model was found for a medium consumption of alcohol (less than 40g/day in men and less than 20g/day in women vs. no consumption).

Table 2. Regression table – univariable associations of sociodemographic, disease and lifestyle factors with elevated respiratory rate.

 < 18.6 brpm
N =  1,916
(86.2%)
 ≥ 18.6 brpm (elevated)
N =  308 (13.8%)
Univariable OR
(95%-CI, p)
Sex Women 1001 (86.7) 154 (13.3)
Men 915 (85.6) 154 (14.4) 1.09 (0.86–1.39, p = 0.464)
Age 39–48 years 417 (88.3) 55 (11.7)
49–58 years 490 (90.4) 52 (9.6) 0.80 (0.54–1.20, p = 0.288)
59–68 years 478 (86.0) 78 (14.0) 1.24 (0.86–1.80, p = 0.259)
69–78 years 383 (83.8) 74 (16.2) 1.46 (1.01–2.14, p = 0.046)
79–88 years 148 (75.1) 49 (24.9) 2.51 (1.63–3.85, p < 0.001)
School education Highest 519 (91.2) 50 (8.8)
Middle 509 (89.0) 63 (11.0) 1.28 (0.87–1.91, p = 0.209)
Lowest 883 (81.9) 195 (18.1) 2.29 (1.66–3.21, p < 0.001)
Living alone Lives with partner 1500 (87.4) 216 (12.6)
Lives without partner 416 (81.9) 92 (18.1) 1.54 (1.17–2.00, p = 0.002)
Waist circumference  ≤ 88 cm in men,
 ≤ 102 cm in women
987 (92.0) 86 (8.0)
 > 88 cm in men,
 > 102 cm in women
928 (80.8) 220 (19.2) 2.72 (2.10–3.56, p < 0.001)
Physical activity Active 1134 (89.1) 139 (10.9)
Inactive 782 (82.2) 169 (17.8) 1.76 (1.38–2.25, p < 0.001)
Smoking Never-smoker 807 (87.1) 119 (12.9)
Ex-smoker 826 (86.4) 130 (13.6) 1.07 (0.82–1.39, p = 0.632)
Smoker 283 (82.7) 59 (17.3) 1.41 (1.00–1.98, p = 0.046)
Alcohol No consumption 507 (83.5) 100 (16.5)
consumption Less than 40g/day in men, 20g/day in women 1057 (87.7) 148 (12.3) 0.71 (0.54–0.94, p = 0.015)
40g/day in men or more, 20g/day in women or more 351 (85.4) 60 (14.6) 0.87 (0.61–1.22, p = 0.420)
Hypertension No current hypertension 1201 (88.6) 154 (11.4)
Current hypertension 711 (82.3) 153 (17.7) 1.68 (1.32–2.14, p < 0.001)
Prior Myocardial No MI 1853 (86.4) 292 (13.6)
infarction MI 58 (78.4) 16 (21.6) 1.75 (0.96–3.01, p = 0.053)
Prior Stroke No stroke 1874 (86.6) 290 (13.4)
Stroke 41 (71.9) 16 (28.1) 2.52 (1.36–4.47, p = 0.002)
Cancer Never cancer 1705 (86.3) 271 (13.7)
Cancer 211 (85.1) 37 (14.9) 1.10 (0.75–1.58, p = 0.605)
Depressive No or little depressive sympt. 1840 (86.5) 286 (13.5)
symptoms Depressive symptoms 74 (77.9) 21 (22.1) 1.83 (1.08–2.96, p = 0.018)
COPD No COPD 1786 (87.2) 263 (12.8)
COPD 124 (74.3) 43 (25.7) 2.35 (1.61–3.38, p < 0.001)
Asthma No asthma 1743 (86.2) 279 (13.8)
Asthma 171 (86.4) 27 (13.6) 0.99 (0.63–1.48, p = 0.950)
Diabetes mellitus Normal glucose tolerance 1287 (90.1) 142 (9.9)
(OGTT) Prediabetes 319 (82.0) 70 (18.0) 1.99 (1.45–2.71, p < 0.001)
Known or new diabetes 239 (74.9) 80 (25.1) 3.03 (2.23–4.11, p < 0.001)
Unclear 71 (81.6) 16 (18.4) 2.04 (1.12–3.52, p = 0.014)
Heart rate Mean (SD) 64.4 (8.9) 74.1 (12.4) 1.10 (1.08–1.11, p < 0.001)
Median (IQR) 64.2 (11.4) 73.9 (16.1)

COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; OGTT: results of the oral glucose tolerance test

Multivariable logistic regression model.

In a multivariable logistic regression model (Fig 4) including 2,194 participants with complete data, elevated respiratory rate was not associated with sex. Participants at the age of 49–58 years had lower odds for an elevated respiratory rate than those in the youngest age group (39–48 years) (OR: 0.60, 95%-CI 0.39–0.92), while the odds in those older than 58 years were not significantly different from the odds in the youngest age group. Low education (OR: 1.77, CI: 1.25–2.55), abdominal obesity (OR: 2.12, CI: 1.58–2.86), diabetes (OR: 1.78, CI: 1.23–2.57), and pre-diabetes (OR: 1.39, CI: 0.99–1.96), smoking (OR: 1.66, CI: 1.13–2.41), and COPD (OR: 1.86, CI: 1.24–2.74) were significantly associated with elevated respiratory rate. Physical activity, alcohol consumption, living alone, myocardial infarction, stroke, depressive symptoms, and hypertension did not reach statistical significance in the adjusted analysis. Multicollinearity was ruled out since all VIF-values were <  2.

Fig 4. Multivariable logistic regression – Association of various disease and lifestyle factors with elevated respiratory rate (N=  2,194 participants with complete data).

Fig 4

Models stratified by sex (S1 and S2 Figs) showed that the lowest school education (n =  549 (47.5%) in women; n =  529 (49.5%) in men) remained significant in women (OR: 2.29, CI: 1.32–4.17), but not in men (OR: 1.49, CI: 0.94–2.40), while diabetes (n =  134 (11.6%) in women; n =  185 (17.3%) in men) and pre-diabetes might play a bigger role in men than in women (OR for diabetes in women: 1.69, CI: 0.98–2.89; OR for diabetes in men: 1.82, CI: 1.08–3.03). However, the inclusion of interaction terms in the combined model revealed non-significant effects, suggesting that these differences may be due to chance or insufficient power.

In a further sensitivity analysis excluding 167 participants with COPD, pre-diabetes was significantly associated with elevated respiratory rate (OR: 1.50, CI: 1.03–2.15) and the odds of the second oldest age group (49–58 years) compared to the youngest age group was not significant anymore. The other factors remained similar (S3 Fig.)

Characteristics of study participants with extreme respiratory rate measurements

Of 2,224 total study participants, 116 had respiratory rate values above their sex- and age-specific 95th-percentiles. 75.9% of them had abdominal obesity; 27.6% had diabetes, 22.4% had pre-diabetes, 26.7% were smokers, 37.9% were ex-smokers, 64.7% were physically inactive, 12.1% had COPD, and 69.0% had the lowest school education. Only two out of these 116 participants (2.6%) did not have any of the mentioned risk factors. One of them suffered from asthma and the other had no relevant comorbidity.

In comparison, of the 2,108 participants who had respiratory rates equal to or below their sex- and age-specific 95th-percentiles, 50.3% had abdominal obesity, 13.6% had diabetes, 17.2% had pre-diabetes, 14.8% were smokers, 43.3% were ex-smokers, 41.6% were physically inactive, 7.3% had COPD, and 47.3% had the lowest school education. In 162 (7.7%) of these individuals, none of the risk factors mentioned above including asthma were present.

Correlation of respiratory rate and heart rate

Heart rate was rather stable across age groups and was higher in women than in men (S3 Table). The median heart rate in women was 65.95 beats per minute (bpm, IQR =  11.38) and 63.91 bpm (IQR =  13.38) in men.

Respiratory rate was positively correlated with heart rate (Kendall’s tau: 0.253, p <  0.001; Spearman’s rho: 0.368, p <  0.001). The median heart rate was 64.20 bpm (IQR =  11.35) in participants with normal and 73.91 bpm (IQR =  16.10) in those with elevated respiratory rates. The 95th-percentile for those with normal respiratory rate was at 79.56 bpm and at 92.41 bpm in those with elevated respiratory rate.

Discussion

To our knowledge, this study describes ECG-derived respiratory rate in a large sample of the general population for the first time. While normal values of respiratory rate have been analyzed in children up to the age of 18 years, there are no population-based references in adults to date. According to 20 observational studies including 3,881 children, Fleming et al. [32] proposed median cut-offs of 43 brpm for newborn to three months old infants, 28 brpm for children aged two to three years, 19 brpm for children aged eight to twelve, 18 brpm for children aged twelve to 15, and 16 brpm for those aged 15 to 18 years. In the KORA FF4 study, median respiratory rate was 16 brpm in participants 39 to 48 years, 15 brpm in those 49 to 58 years, 16 brpm in those 59 to 68 years, 16 brpm in those 69 to 78 years, and 17 brpm in those 79 to 88 years old.

308 participants (13.8%) had an elevated respiratory rate ≥ 18.6 brpm. The odds of an elevated respiratory rate were higher with increasing age, with the presence of metabolic, cardiovascular, and pulmonary comorbidities, with low physical activity, active smoking, and with socioeconomic and psychosocial factors such as low school education, depression, and living without a partner. In a multivariable regression model, the following factors were independently associated with an increased respiratory rate:

Abdominal obesity

The results of our study confirm that individuals with obesity (especially abdominal obesity) have higher respiratory rates. This is probably due to reduced tidal volumes and pulmonary restriction caused by the distribution of fat especially in the upper body. Thus, using waist circumference instead of BMI as an indicator of abdominal obesity is a reasonable and recommended alternative [33]. As summarized in a review by Littleton, several studies showed that pulmonary ventilation including total lung capacity, expiratory reserve volume, and functional residual capacity are affected by obesity. Interestingly, most of the effects of obesity on respiration are reversible by weight loss, which indicates that they may be caused by obesity itself [34].

Diabetes

Known and newly diagnosed diabetes as well as pre-diabetes determined by an OGTT were associated with elevated respiratory rate, especially in men. An impaired lung function in patients with diabetes has been described in several reviews [3537]. Obesity and cardiovascular diseases are frequent comorbidities in individuals with diabetes, which is why these factors were included as covariates in our models, however, diabetes itself appears to affect respiration. As outlined by Lecube et al., it has a damaging effect on the lung due to insulin and leptin resistance, chronic inflammation, autonomic neuropathy, and microvascular impairments. In the process, alveolar epithelia get thicker, the alveolar space is reduced, there are higher degrees of fibrosis, and a higher risk of sleep apnea. The authors recommend considering patients with diabetes as a vulnerable group for pulmonary dysfunction [38]. Interestingly, there is an ongoing discussion on whether reduced lung function may be a risk factor for incident diabetes as well [35,39]. Choi et al. conducted a longitudinal study in 3,864 adults in Korea and reported that lower forced vital capacity and lower forced expiratory volume predicted the onset of diabetes independently of many potential covariates and in a graded fashion [40]. Another current research question regards strength and function of the respiratory muscles: Schein et al. hypothesized that inspiratory muscle exercise as an alternative to conventional physical activity might lower glucose levels in patients with diabetes. In a small, randomized trial, they found that this type of exercise induced cardiovascular changes, however, it failed to improve glucose, glucose variability and autonomic control in their experimental setting [41].

Smoking and COPD

In our adjusted regression model, we found significant associations of smoking and COPD with elevated respiratory rate. Smoking is a known causal risk factor of COPD and both smoking and COPD impair the pulmonary system [42]. Specifically, they lead to small airway narrowing and lower gas exchange rates [43] and, intuitively, they often result in higher respiratory rates to keep up the pulmonary gas exchange. Furthermore, toxins in cigarette smoke irritate the airways; activation of the sympathetic nervous system due to nicotine stimulation, chronic inflammation and swelling, mucus overproduction, cilia dysfunction, and alveolar damage among other factors may contribute to an elevated respiratory rate [4446].

School education

Even after adjustment for various confounding factors, low school education was still clearly associated with elevated respiratory rate. This observation indicates that further factors associated with low socio-economic status, such as disadvantageous living conditions at the place of residence (e.g., air pollution and noise) and unfavorable life circumstances (e.g., stress, unhealthy nutrition, sleep deprivation) may play a role [47]. Moreover, people with lower education are more often exposed to unhealthy working environments (e.g., to dust, chemicals, and vapors in the construction industry, agriculture, or production) and might have experienced more detrimental influences during gestation and childhood (e.g., exposure to passive smoke, less healthy nutrition) [48].

Our study reconciles disease, lifestyle, and socioeconomic factors associated with respiratory rate and indicates that the vital sign has remarkable diagnostic potential. It no longer requires special sensor technology and is easy to derive from ECGs in the clinical and ambulatory setting as well as from wearables. Thus, people with an increased respiratory rate should be examined and followed up more closely to detect and possibly prevent diseases and unfavorable progressions at an early stage.

Strengths and limitations

A strength of the KORA study is its large sample size from the general population with rich phenotyping including ECG measurements. Moreover, the data were collected in a highly standardized manner. Breathing is very subjective, so measuring the respiratory rate while the patient or subject knows what is being measured can lead to altered results. One way to address this problem would be to take longer measurements and delete the first few minutes of them. However, this method is cumbersome and difficult to scale. Therefore, using ECG data is a very elegant way to determine respiratory rate without the described bias. Moreover, ECGs are universally available, scalable, the respiratory rate can be determined from any recorded ECG data set, and the standardized measurement can be easily reproduced.

There are certain limitations to our work as well: The study-design was cross-sectional and based on the second follow-up approximately 13 years after baseline, which might have introduced some selection bias. The results of our study may not be generalizable to other ethnicities or populations with different demographic or different health profiles. Lifestyle and disease records relied on self-report by the participants. Information on cardiac insufficiency, a condition that may also be associated with increased respiratory rate, was not available. Our results are adjusted for numerous known confounders, however, there might be additional unrecognized effects. Finally, participants were asked to take shallow breaths during the recording of the ECG, which might have influenced respiratory frequency in some individuals.

Conclusions

Respiratory rate is an age-dependent vital sign. It is easy to measure and can be calculated indirectly from electrocardiogram recordings, avoiding distortion by the person’s awareness and voluntary control of breathing.

Increased respiratory rate is independently associated with obesity, diabetes, smoking, COPD, and low school education. It appears to be an indicator for impaired health especially regarding pulmonary and metabolic characteristics, and for unfavorable lifestyle and living conditions. To further confirm the predictive value of elevated respiratory rate on morbidity and mortality, studies with longer observation periods are needed.

Supporting information

S1 File. SupportingInfo_RespiratoryRate_PlosOne_Rueckert.

(PDF)

pone.0318502.s001.pdf (837.8KB, pdf)

Acknowledgments

We thank all participants for their long-term commitment to the KORA study, the staff for data collection and research data management and the members of the KORA Study Group

(https://www.helmholtz-munich.de/en/epi/cohort/kora) who are responsible for the design and

conduct of the study.

Abbreviations

BMI,

Body mass index;

KORA,

Cooperative Health Research in the Region of Augsburg; bpm, Beats per minute;

OGTT,

Oral glucose tolerance test;

brpm,

Breaths per minute;

VIF,

Variance inflation factor;

COPD,

Chronic obstructive pulmonary disease;

WC,

Waist circumference;

ECG,

Electrocardiogram.

Data Availability

The dataset analyzed during the current study is not publicly available due to national data protection laws, since the informed consent given by KORA study participants does not cover data posting in public databases. Data are available upon request by means of a project agreement from KORA. Requests should be sent to kora.passt@helmholtz-munich.de and are subject to approval by the KORA Board.

Funding Statement

The KORA study was initiated and financed by the Helmholtz Zentrum München – German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Data collection in the KORA study is done in cooperation with the University Hospital of Augsburg. The study was supported by the DZHK (German Centre for Cardiovascular Research, https://dzhk.de/en/) via grants to AP, GS, and KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hippocrates. The Book of Prognostics: The Internet Classics Archive; 400 BCE [Available from: The Internet Classics Archive. http://classics.mit.edu//Hippocrates/prognost.html. [Last accessed on 03 Dec 2024]. [Google Scholar]
  • 2.Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. doi: 10.1001/jama.2016.0287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Steichen O, Grateau G, Bouvard E. Respiratory rate: the neglected vital sign. Med J Aust. 2008;189(9):531–2. doi: 10.5694/j.1326-5377.2008.tb02164.x [DOI] [PubMed] [Google Scholar]
  • 4.Churpek MM, Yuen TC, Winslow C, Meltzer DO, Kattan MW, Edelson DP. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit Care Med. 2016;44(2):368–74. doi: 10.1097/CCM.0000000000001571 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Shappell C, Snyder A, Edelson DP, Churpek MM, American Heart Association’s Get With The Guidelines-Resuscitation Investigators. Predictors of in-hospital mortality after rapid response team calls in a 274 hospital nationwide sample. Crit Care Med. 2018;46(7):1041–8. doi: 10.1097/CCM.0000000000002926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Takayama A, Takeshima T, Yamazaki H, Kamitani T, Shimizu S, Fukuhara S, et al. Resting respiration rate predicts all-cause mortality in older outpatients. Aging Clin Exp Res. 2022;34(7):1697–705. doi: 10.1007/s40520-022-02104-0 [DOI] [PubMed] [Google Scholar]
  • 7.Baumert M, Linz D, Stone K, McEvoy R, Cummings S, Redline S. Mean nocturnal respiratory rate predicts cardiovascular and all-cause mortality in community-dwelling older men and women. Eur Respir J. 2019;54(1):1802175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pingali H, Hunter S. Exploring mechanisms of blood pressure regulation in response to device-guided and non-device-guided slow breathing: a mini review. Auton Neurosci. 2023;244:103050. [DOI] [PubMed] [Google Scholar]
  • 9.Chaitanya S, Datta A, Bhandari B, Sharma V. Effect of resonance breathing on heart rate variability and cognitive functions in young adults: a randomised controlled study. Cureus. 2022;14(2):e22187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ma X, Yue Z, Gong Z, Zhang H, Duan N, Shi Y. The effect of diaphragmatic breathing on attention, negative affect and stress in healthy adults. Front Psychol. 2017;8874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Joseph AE, Moman RN, Barman RA, Kleppel DJ, Eberhart ND, Gerberi DJ, et al. Effects of slow deep breathing on acute clinical pain in adults: a systematic review and meta-analysis of randomized controlled trials. J Evid Based Integr Med. 2022;27:2515690X221078006. doi: 10.1177/2515690X221078006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Streeter CC, Gerbarg PL, Whitfield TH, Owen L, Johnston J, Silveri MM, et al. Treatment of major depressive disorder with iyengar yoga and coherent breathing: a randomized controlled dosing study. J Altern Complement Med. 2017;23(3):201–7. doi: 10.1089/acm.2016.0140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Flenady T, Dwyer T, Applegarth J. Accurate respiratory rates count: So should you! Australas Emerg Nurs J. 2017;20(1):45–7. doi: 10.1016/j.aenj.2016.12.003 [DOI] [PubMed] [Google Scholar]
  • 14.Cretikos MA, Bellomo R, Hillman K, Chen J, Finfer S, Flabouris A. Respiratory rate: the neglected vital sign. Med J Aust. 2008;188(11):657–9. doi: 10.5694/j.1326-5377.2008.tb01825.x [DOI] [PubMed] [Google Scholar]
  • 15.Nicolò A, Massaroni C, Schena E, Sacchetti M. The importance of respiratory rate monitoring: from healthcare to sport and exercise. Sensors (Basel). 2020;20(21):6396. doi: 10.3390/s20216396 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rodríguez-Molinero A, Narvaiza L, Ruiz J, Gálvez-Barrón C. Normal respiratory rate and peripheral blood oxygen saturation in the elderly population. J Am Geriatr Soc. 2013;61(12):2238–40. doi: 10.1111/jgs.12580 [DOI] [PubMed] [Google Scholar]
  • 17.Bauer A, Kantelhardt JW, Barthel P, Schneider R, Mäkikallio T, Ulm K, et al. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet. 2006;367(9523):1674–81. doi: 10.1016/S0140-6736(06)68735-7 [DOI] [PubMed] [Google Scholar]
  • 18.Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999;353(9162):1390–6. doi: 10.1016/S0140-6736(98)08428-1 [DOI] [PubMed] [Google Scholar]
  • 19.Barthel P, Wensel R, Bauer A, Müller A, Wolf P, Ulm K, et al. Respiratory rate predicts outcome after acute myocardial infarction: a prospective cohort study. Eur Heart J. 2013;34(22):1644–50. doi: 10.1093/eurheartj/ehs420 [DOI] [PubMed] [Google Scholar]
  • 20.Kantelhardt JW, Bauer A, Schumann AY, Barthel P, Schneider R, Malik M, et al. Phase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk. Chaos. 2007;17(1):015112. doi: 10.1063/1.2430636 [DOI] [PubMed] [Google Scholar]
  • 21.Steger A, Dommasch M, Müller A, Barthel P, Sinnecker D, Wieg L, et al. The polyscore of autonomic parameters predicts mortality and identifies low-risk individuals among diabetic survivors of acute myocardial infarction. Sci Rep. 2022;12(1):6069. doi: 10.1038/s41598-022-09899-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Steger A, Dommasch M, Müller A, Sinnecker D, Huster KM, Gotzler T, et al. Polyscore of autonomic parameters for risk stratification of the elderly general population: the Polyscore study. Europace. 2021;23(5):789–96. doi: 10.1093/europace/euaa359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Beall CM. Andean, Tibetan, and Ethiopian patterns of adaptation to high-altitude hypoxia. Integr Comp Biol. 2006;46(1):18–24. doi: 10.1093/icb/icj004 [DOI] [PubMed] [Google Scholar]
  • 24.Holle R, Happich M, Löwel H, Wichmann HE, MONICA/KORA Study Group. KORA--a research platform for population based health research. Gesundheitswesen. 2005;67(Suppl 1):S19-25. doi: 10.1055/s-2005-858235 [DOI] [PubMed] [Google Scholar]
  • 25.Laxy M, Knoll G, Schunk M, Meisinger C, Huth C, Holle R. Quality of diabetes care in germany improved from 2000 to 2007 to 2014, but improvements diminished since 2007. evidence from the population-based KORA studies. PLoS One. 2016;11(10):e0164704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sinnecker D, Dommasch M, Barthel P, Müller A, Dirschinger RJ, Hapfelmeier A, et al. Assessment of mean respiratory rate from ECG recordings for risk stratification after myocardial infarction. J Electrocardiol. 2014;47(5):700–4. doi: 10.1016/j.jelectrocard.2014.04.021 [DOI] [PubMed] [Google Scholar]
  • 27.Steger A, Müller A, Barthel P, Dommasch M, Huster KM, Hnatkova K, et al. Polyscore of non-invasive cardiac risk factors. Front Physiol. 2019;10:49. doi: 10.3389/fphys.2019.00049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Meisinger C, Löwel H, Thorand B, Döring A. Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population. The MONICA/KORA Augsburg cohort study. Diabetologia. 2005;48(1):27–34. doi: 10.1007/s00125-004-1604-3 [DOI] [PubMed] [Google Scholar]
  • 29.Döring A, Filipiak B, Stieber J, Keil U. Trends in alcohol intake in a southern German population from 1984-1985 to 1989-1990: results of the MONICA Project Augsburg. J Stud Alcohol. 1993;54(6):745–9. doi: 10.15288/jsa.1993.54.745 [DOI] [PubMed] [Google Scholar]
  • 30.Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ. 1995;311(6998):158–61. doi: 10.1136/bmj.311.6998.158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Huth C, von Toerne C, Schederecker F, de Las Heras Gala T, Herder C, Kronenberg F, et al. Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study. Eur J Epidemiol. 2019;34(4):409–22. doi: 10.1007/s10654-018-0475-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377(9770):1011–8. doi: 10.1016/S0140-6736(10)62226-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16(3):177–89. doi: 10.1038/s41574-019-0310-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Littleton SW. Impact of obesity on respiratory function. Respirology. 2012;17(1):43–9. doi: 10.1111/j.1440-1843.2011.02096.x [DOI] [PubMed] [Google Scholar]
  • 35.Klein O, Krishnan J, Glick S, Smith L. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med. 2010;27(9):977–87. [DOI] [PubMed] [Google Scholar]
  • 36.van den Borst B, Gosker HR, Zeegers MP, Schols AMWJ. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406. doi: 10.1378/chest.09-2622 [DOI] [PubMed] [Google Scholar]
  • 37.Diez-Manglano J, Asin Samper U. Pulmonary function tests in type 2 diabetes: a meta-analysis. ERJ Open Research. n.d.;7(1):page range here. doi: DOIhere [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lecube A, Simó R, Pallayova M, Punjabi NM, López-Cano C, Turino C, et al. Pulmonary function and sleep breathing: two new targets for type 2 diabetes care. Endocr Rev. 2017;38(6):550–73. doi: 10.1210/er.2017-00173 [DOI] [PubMed] [Google Scholar]
  • 39.James A. Diabetes and lung function: linked, but how?. Respirology. 2024;29(5):361–2. doi: DOI_OR_IDENTIFIER [DOI] [PubMed] [Google Scholar]
  • 40.Choi HS, Lee SW, Kim JT, Lee HK. The association between pulmonary functions and incident diabetes: longitudinal analysis from the ansung cohort in Korea. Diabetes Metab J. 2020;44(5):699–710. doi: 10.4093/dmj.2019.0109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Schein A, Correa A, Macedo A, Dartora D, da Silveira A, Severo M. Acute inspiratory muscle exercise effect on glucose levels, glucose variability and autonomic control in patients with type 2 diabetes: A crossover randomized trial. Autonomic Neuroscience. 2020;226:102669. [DOI] [PubMed] [Google Scholar]
  • 42.Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med. 2011;11:36. doi: 10.1186/1471-2466-11-36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Adatia A, Wahab M, Shahid I, Moinuddin A, Killian KJ, Satia I. Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects. PLoS One. 2021;16(6):e0250957. doi: 10.1371/journal.pone.0250957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA. The presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease development. Am J Respir Crit Care Med. 2016;193(6):662–72. doi: 10.1164/rccm.201511-2210OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014;64(16):1740–50. doi: 10.1016/j.jacc.2014.06.1201 [DOI] [PubMed] [Google Scholar]
  • 46.Yoshida T, Tuder R. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiological Reviews. 2007;87(3):1047–82. [DOI] [PubMed] [Google Scholar]
  • 47.Maier W, Holle R, Hunger M, Peters A, Meisinger C, Greiser KH, et al. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. a pooled analysis of five population-based studies. Diabet Med. 2013;30(3):e78-86. [DOI] [PubMed] [Google Scholar]
  • 48.Houweling TAJ, Grünberger I. Intergenerational transmission of health inequalities: towards a life course approach to socioeconomic inequalities in health - a review. J Epidemiol Community Health. 2024;78(10):641–9. doi: 10.1136/jech-2022-220162 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. SupportingInfo_RespiratoryRate_PlosOne_Rueckert.

(PDF)

pone.0318502.s001.pdf (837.8KB, pdf)

Data Availability Statement

The dataset analyzed during the current study is not publicly available due to national data protection laws, since the informed consent given by KORA study participants does not cover data posting in public databases. Data are available upon request by means of a project agreement from KORA. Requests should be sent to kora.passt@helmholtz-munich.de and are subject to approval by the KORA Board.


Articles from PLOS One are provided here courtesy of PLOS

RESOURCES